351 completed, 229 unknown, 99 recruiting, 55 not yet recruiting. 243 Not applicable, 114 Phase 4, 94 Phase 3, 84 Phase 2, 13 Phase 1.
Follow ST Elevation Myocardial Infarction: new trials by email Literature Review of ST Elevation Myocardial Infarction trials Research Report on ST Elevation Myocardial Infarction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Germany on Target Registry No study-assigned intervention - Myocardial Infarction (MI), Dyslipidemias | Not yet recruiting | Deutsche Gesellschaft für Lipidologie e. V. (DGFL) - Lipid-Liga | 10000 | 2026-12-01 | 2026-09-28 | |
| Hong Kong Cardiogenic Shock Initiative Cardiogenic Shock Acute, STEMI - ST Elevation Myocardial Infarction | Not yet recruiting | Prince of Wales Hospital, Shatin, Hong Kong | 320 | 2026-12-01 | 2026-09-16 | |
| AI-ECG Detection of Occlusion Myocardial Infarction at Emergency Department Triage (TRIACS) Acute Coronary Syndromes, Chest Pain | Not yet recruiting | University Medical Centre Maribor | 1000 | 2026-10-19 | 2026-10-20 | |
| On vs Off-hour PPCI in STEMI Patients Acute STEMI, PPCI | Not yet recruiting | Assiut University | 450 | 2026-10-15 | 2026-10-06 | |
| CHIP in Health and Disease Clonal Hematopoiesis, Clonal Hematopoiesis of Indeterminate Potential | Not yet recruiting | VASCage GmbH | 120 | 2026-10-01 | 2026-09-21 | |
| Beyond the Mehran Risk Score: Predictive Value of Total Ischemic Time for Contrast-Induced Nephropathy in ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. Total Ischemic Time Evaluation - ST Elevation (STEMI) Myocardial Infarction, Contrast Induced Nephropathy (CIN) | Not yet recruiting | Assiut University | 400 | 2026-10-01 | 2026-09-17 | |
| Optimal Timing of Microaxial Flow Pump(Impella CP) in AMI-related Cardiogenic Shock Routine pre-PCI Impella CP, Selective post-PCI Impella CP - Myocardial Infarction (MI), Cardiogenic Shock | Not applicable | Not yet recruiting | Chonnam National University Hospital | 126 | 2026-10-01 | 2026-09-14 |
| Multimodality Assessment of Myocardial Reperfusion After Primary Percutaneous Coronary Intervention ST Elevation (STEMI) Myocardial Infarction, Microvascular Obstruction (MVO) | Not yet recruiting | Assiut University | 90 | 2026-10-01 | 2026-10-15 | |
| IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI Recombinant Streptokinase - ST Elevation Myocardial Infarction (STEMI) | Phase 4 | Not yet recruiting | The Affiliated Hospital of Xuzhou Medical University | 3300 | 2026-09-28 | 2026-10-15 |
| Smartphone AI Assistance for Prehospital ECG Interpretation Smartphone large language model assistance (GPT-4o, version-locked) - Acute Coronary Syndromes, ST Elevation Myocardial Infarction | Not applicable | Recruiting | École Supérieure de Soins Ambulanciers - College of Higher Education in Prehospital Care | 144 | 2026-09-02 | 2026-09-09 |
| Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients empagliflozin, Placebo - ST-elevation Myocardial Infarction (STEMI), Acute Myocardial Infarction (AMI) | Phase 2 | Not yet recruiting | Rehman Medical Institute - RMI | 480 | 2026-09-01 | 2026-08-06 |
| Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARL Pelacarsen, Placebo - Acute Coronary Syndrome (ACS) | Phase 3 | Withdrawn | Novartis Pharmaceuticals | 2026-09-01 | 2026-10-14 | |
| Combined Antioxidant Therapy for Acute Myocardial Infarction Combined antioxidant therapy, Placebo - Acute Myocardial Infarction (AMI), ST Elevation (STEMI) Myocardial Infarction | Phase 2 | Not yet recruiting | University of Chile | 46 | 2026-09-01 | 2026-08-20 |
| Integrated Assessment of Immune-Inflammatory and Metabolic Biomarkers for Prediction of Coronary No-Reflow Following Primary PCI in STEMI Patients Assessment of immune-inflammatory and metabolic biomarkers - Integrated Assessment, Immune-Inflammatory | Recruiting | Sohag University | 400 | 2026-09-01 | 2026-10-22 | |
| Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome bempedoic acid, Ezetimibe, High-Intensity Statin Therapy - Acute Coronary Syndromes, Dyslipidemia | Phase 4 | Recruiting | Taipei Medical University Hospital | 400 | 2026-08-26 | 2026-09-17 |
| Abbreviated Antithrombotic Therapy After PCI in Patients With AF and AMI DAT (DOAC+clopidogrel), DOAC monotherapy - Myocardial Infarction (MI), ST-Segment Elevation Myocardial Infarction(STEMI) | Not applicable | Recruiting | Chonnam National University Hospital | 860 | 2026-08-26 | 2026-09-02 |
| Noninvasive Artificial Venous Stasis for Reperfusion in STEMI STEMI - ST Elevation Myocardial Infarction | Recruiting | Firat University | 500 | 2026-08-15 | 2026-08-18 | |
| SMARTwatch for the Diagnosis of ST-segment Elevation Myocardial Infarction in Patients With Chest Pain ECG smartwatch recording - STEMI - ST-segment Elevation Myocardial Infarction, Chest Pain | Recruiting | Hospital General Universitario Santa Lucia | 100 | 2026-08-14 | 2026-08-26 | |
| Drug-coatEd Balloon Multicentric Registry in Spain and PORTugal Coronary Artery Disease (CAD), ST-elevation Myocardial Infarction (STEMI) | Not yet recruiting | Portuguese Association of Interventional Cardiology | 1200 | 2026-08-01 | 2026-03-17 | |
| Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients. PCI - STEMI, No-Reflow Phenomenon | Not yet recruiting | Assiut University | 100 | 2026-08-01 | 2026-07-16 |
Showing 20 of 826. Sign in to see all of them.
Myocardial Infarction (179) · Non-ST Elevated Myocardial Infarction (154) · Acute Coronary Syndrome (108) · Coronary Artery Disease (76) · Angina, Unstable (51) · Cardiovascular Diseases (32) · Myocardial Ischemia (32) · Angina, Stable (23) · Coronary Disease (21) · Ischemia (20) · Heart Failure (19) · Reperfusion Injury (19) · Angina Pectoris (18) · Diabetes Mellitus (18)
Pathological Conditions, Signs and Symptoms (826) · Necrosis (824) · Pathologic Processes (824) · Vascular Diseases (819) · Infarction (814) · Heart Diseases (813) · Ischemia (806) · Cardiovascular Diseases (794) · Myocardial Ischemia (794) · Myocardial Infarction (647) · Signs and Symptoms (86) · Neurologic Manifestations (82) · Arteriosclerosis (80) · Pain (80) · Arterial Occlusive Diseases (78)
Ticagrelor (37) · Percutaneous Coronary Intervention (33) · Clopidogrel (23) · Prasugrel Hydrochloride (19) · Sodium Chloride (18) · Aspirin (15) · Heparin (13) · Atorvastatin (12) · Saline Solution (11) · Standard of Care (11) · bivalirudin (11) · cangrelor (10) · Drug-Eluting Stents (9) · Tirofiban (9) · Rivaroxaban (8)
Assiut University (32) · RenJi Hospital (13) · Copenhagen University Hospital, Rigshospitalet (10) · Assistance Publique - Hôpitaux de Paris (9) · Chinese PLA General Hospital (9) · Beijing Anzhen Hospital (8) · Karolinska Institutet (8) · Harbin Medical University (7) · Samsung Medical Center (7) · University College, London (7) · Henan Institute of Cardiovascular Epidemiology (6) · Hospices Civils de Lyon (6) · Medical University of Vienna (6) · Miracor Medical SA (6) · Population Health Research Institute (6)
China (141) · United States (82) · Italy (67) · United Kingdom (50) · France (48) · Germany (48) · Canada (41) · Netherlands (41) · Spain (40) · Denmark (37) · South Korea (35) · Poland (30) · Egypt (28) · Switzerland (25) · Sweden (24)
Gregg Stone, MD (3) · Joo Myung Lee, MD, MPH, PhD (3) · Joo-Yong Hahn, MD, PhD (3) · Young Joon Hong, MD, PhD (3) · Abdul Hakeem, MD (2) · Adrian Banning, Prof. (2) · Alan S Maisel, MD (2) · Anselm K Gitt, MD (2) · Astrid D Sloth, MD (2) · Ben He, MD,PhD (2) · Bo Yu (2) · Bon-Kwon Koo, MD, PhD (2) · Cheol Woong Yu, M.D.,Ph.D. (2) · Christian Mueller, MD (2)
PMID 26347918, PMID 28886621, PMID 36526898, PMID 19915221, PMID 23500251, PMID 24962156, PMID 25965708, PMID 28249094, PMID 29122844, PMID 29776961, PMID 30354595, PMID 31005537, PMID 31126887, PMID 31475795, PMID 33951923, PMID 33999545, PMID 34785173, PMID 35990971, PMID 37622654, PMID 40014670, PMID 40888716, PMID 41493904, PMID 41934630, PMID 10051376, PMID 11277825, PMID 11376301, PMID 11877368, PMID 12517460, PMID 12607706, PMID 1291482, PMID 14578250, PMID 14760193, PMID 15007110, PMID 15007111, PMID 15791442, PMID 15861319, PMID 15956631, PMID 15984909, PMID 16168297, PMID 16327043, PMID 16337036, PMID 16371925, PMID 16537725, PMID 16545122, PMID 16803939, PMID 16916504, PMID 16925605, PMID 16949492, PMID 17000940, PMID 17394957
2018 (6), 2025 (4), 2016 (3), 2014 (2), 2015 (1), 2017 (1), 2019 (1), K23AT009715 (1), R01HL103927 (1), R01HL146206 (1), R44HL091699 (1)